Journal: Journal of Child and Adolescent Psychopharmacology
Article Title: A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
doi: 10.1089/cap.2015.0261
Figure Lengend Snippet: Mean total methylphenidate plasma concentration–time profiles for MPH XR-ODT under fasted conditions in children and adolescents by age. MPH XR-ODT, methylphenidate extended-release orally disintegrating tablets.
Article Snippet: A new orally disintegrating tablet (ODT) formulation of MPH, which provides a PK profile consistent with once-daily dosing, has been developed by Neos Therapeutics, Inc. (NT0102 [MPH XR-ODT]; Childress et al. ).
Techniques: Clinical Proteomics, Concentration Assay